8 followers
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet ag... Read more
Laurent Fischer
4D Molecular Therapeutics
3 followers
Pivot Bio
2 followers
Quantum-Si
2 followers
Jnana Therapeutics
1 follower
Sonoma Biotherapeutics
1 follower
Thermo Fisher Scientific
159 followers
Regeneron
91 followers
Roivant Sciences
56 followers
Natera
13 followers
10X Genomics
13 followers
Neurocrine Biosciences
5 followers
Explore companies